/PRGO
PRGO Stock - Perrigo Company plc
Healthcare|Drug Manufacturers - Specialty & GenericNYSE
$15.06+0.80%
+$0.12 (+0.80%) • Jan 13
73
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.31
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+42.8%upside
Target: $21.51
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PRGO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$14.91 – $15.21
TARGET (TP)$21.50
STOP LOSS$13.86
RISK/REWARD1:5.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.40
52W High$30.93
52W Low$12.17
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.37B | $4.66B | $4.45B | $4.14B | $4.09B |
| Gross Profit | $1.54B | $1.68B | $1.46B | $1.42B | $1.49B |
| Gross Margin | 35.3% | 36.1% | 32.7% | 34.2% | 36.6% |
| Operating Income | $112.90M | $151.90M | $78.90M | $410.40M | $265.20M |
| Net Income | $-171,800,000 | $-12,700,000 | $-140,600,000 | $-68,900,000 | $-162,600,000 |
| Net Margin | -3.9% | -0.3% | -3.2% | -1.7% | -4.0% |
| EPS | $-1.25 | $-0.09 | $-0.97 | $-0.98 | $-1.19 |
Company Overview
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
33%
Hold / Neutral
4
67%
Sell / Underperform
0%
Analyst Consensus🔴 Bearish
2 Bullish4 Neutral/Bearish
Price Targets
$38
Average Target
↑ 149.5% Upside
Now
$20
Low
$38
Average
$54
High
Based on 7 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 6th 2025 | JP Morgan | Downgrade | Neutral | $20 |
| January 14th 2025 | Argus | Downgrade | Hold | - |
| January 6th 2025 | Piper Sandler | Downgrade | Neutral | $27← $34 |
| September 24th 2024 | Jefferies | Resumed | Hold | $30← $50 |
| November 17th 2023 | Piper Sandler | Initiation | Overweight | $37 |
| March 7th 2023 | Canaccord Genuity | Initiation | Buy | $49 |
| September 14th 2022 | Argus | Upgrade | Buy | $46 |
| September 6th 2022 | Wells Fargo | Upgrade | Overweight | $54← $48 |
Earnings History & Surprises
PRGOBeat Rate
53%
Last 19 quarters
Avg Surprise
-0.9%
EPS vs Estimate
Beats / Misses
10/9
Last 12 quarters
Latest EPS
$0.80
Q4 2025
EPS Surprise History
Q1 24
+3.6%
$0.86vs$0.83
Q2 24
+20.8%
$0.29vs$0.24
Q3 24
+10.4%
$0.53vs$0.48
Q4 24
-1.2%
$0.81vs$0.82
Q1 25
+1.1%
$0.93vs$0.92
Q2 25
+7.1%
$0.60vs$0.56
Q3 25
-3.4%
$0.57vs$0.59
Q4 25
+6.7%
$0.80vs$0.75
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 26, 2026 | $0.78 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.75 | $0.80 | +6.7% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $0.59 | $0.57 | -3.4% | ✗ MISS |
Q2 2025 | May 7, 2025 | $0.56 | $0.60 | +7.1% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $0.92 | $0.93 | +1.1% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $0.82 | $0.81 | -1.2% | ✗ MISS |
Q3 2024 | Aug 2, 2024 | $0.48 | $0.53 | +10.4% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $0.24 | $0.29 | +20.8% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $0.83 | $0.86 | +3.6% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.65 | $0.64 | -1.5% | ✗ MISS |
Q3 2023 | Aug 8, 2023 | $0.54 | $0.63 | +16.7% | ✓ BEAT |
Q2 2023 | May 9, 2023 | $0.42 | $0.45 | +7.1% | ✓ BEAT |
Q1 2023 | Feb 27, 2023 | $0.70 | $0.75 | +7.1% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $0.66 | $0.56 | -15.2% | ✗ MISS |
Q3 2022 | Aug 9, 2022 | $0.44 | $0.43 | -2.3% | ✗ MISS |
Q2 2022 | May 11, 2022 | $0.42 | $0.33 | -21.4% | ✗ MISS |
Q1 2022 | Mar 1, 2022 | $0.56 | $0.60 | +7.1% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $0.65 | $0.45 | -30.8% | ✗ MISS |
Q3 2021 | Aug 11, 2021 | $0.61 | $0.50 | -18.0% | ✗ MISS |
Q2 2021 | May 11, 2021 | $0.56 | $0.50 | -10.7% | ✗ MISS |
Latest News
Primoris Services, Casella Waste Systems, Indivior, Hawaiian Electric, LKQ, Solstice Advanced Materials, Mohawk Industries, Under Armour, Power Integrations, Perrigo, Iridium Communications, Marriott Vacations Worldwide And Insperity Added To S&P SmallCap 600
📈 PositiveBenzinga•Dec 5, 2025, 10:27 PM•Also: , ,
UL Solutions, Pinterest, Booz Allen Hamilton, SPX Technologies, Dycom Industries, Borgwarner And Hecla Mining Co Set To S&P MidCap 400 December 22, 2025; Comfort Systems USA, Under Armour, Power Integrations, Perrigo, Iridium Communications, Marriott Vacations Worldwide And Insperity Exit S&P MidCap 400
📈 PositiveBenzinga•Dec 5, 2025, 10:24 PM•Also: , ,
Canaccord Genuity Maintains Buy on Perrigo, Lowers Price Target to $20
➖ NeutralBenzinga•Nov 6, 2025, 08:10 PM•Also:
JP Morgan Downgrades Perrigo to Neutral, Lowers Price Target to $20
📉 NegativeBenzinga•Nov 6, 2025, 12:46 PM
Perrigo shares are trading lower after the company reported mixed Q3 financial results and cut its FY25 adjusted EPS guidance below estimates.
📉 NegativeBenzinga•Nov 5, 2025, 01:50 PM
Perrigo Lowers FY2025 Adj EPS Guidance from $2.90-$3.10 to $2.70-$2.80 vs $2.98 Est
📉 NegativeBenzinga•Nov 5, 2025, 11:38 AM
Perrigo Q3 Adj. EPS $0.80 Beats $0.75 Estimate, Sales $1.043B Miss $1.097B Estimate
➖ NeutralBenzinga•Nov 5, 2025, 11:37 AM
Perrigo Starts Strategic Review Of Its Infant Formula Operations
➖ NeutralBenzinga•Nov 5, 2025, 11:31 AM
Jefferies Maintains Hold on Perrigo, Lowers Price Target to $23
📉 NegativeBenzinga•Oct 27, 2025, 01:21 PM•Also:
Reported Earlier, President Trump Starting October 1st 2025 Imposes 100% Tariff On Branded Or Patented Pharmaceutical Products Unless Company Is Building Plant In America
📉 NegativeBenzinga•Sep 26, 2025, 05:43 AM•Also: ,
'Local 210 Calls Out Pharmaceutical Manufacturer For Trying To Slash Workers' Benefits; Members Of Teamsters Local 210 Are On Strike At Perrigo Company's Bronx Manufacturing Facilities' - Teamsters
📉 NegativeBenzinga•Sep 5, 2025, 07:03 PM
Frequently Asked Questions about PRGO
What is PRGO's current stock price?
Perrigo Company plc (PRGO) is currently trading at $15.06 per share. The stock has moved +0.80% today.
What is the analyst price target for PRGO?
The average analyst price target for PRGO is $21.50, based on 1 analyst.
What sector is Perrigo Company plc in?
Perrigo Company plc operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the NYSE exchange.
What is PRGO's market cap?
Perrigo Company plc has a market capitalization of $2.07 billion, making it a mid-cap company.
Does PRGO pay dividends?
No, Perrigo Company plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATEC
Alphatec Holdings, Inc.
$16.45
Mkt Cap: $2.4B
BHC
Bausch Health Companies Inc.
$7.50
Mkt Cap: $2.8B
FOLD
Amicus Therapeutics, Inc.
$14.32
Mkt Cap: $4.4B
HCM
HUTCHMED (China) Limited
$14.95
Mkt Cap: $2.7B
HTFL
Heartflow, Inc. Common Stock
$32.07
Mkt Cap: $2.7B
LIVN
LivaNova PLC
$61.33
Mkt Cap: $3.3B
SGRY
Surgery Partners, Inc.
$16.08
Mkt Cap: $2.1B
SRRK
Scholar Rock Holding Corporation
$43.75
Mkt Cap: $4.5B
SUPN
Supernus Pharmaceuticals, Inc.
$51.45
Mkt Cap: $2.9B
TARS
Tarsus Pharmaceuticals, Inc.
$75.73
Mkt Cap: $3.2B
Explore stocks similar to PRGO for comparison